Notably, in immune replete syngeneic mouse models, it has been reported that blockade of VEGFR-2 but not VEGFR-1 or VEGFR-3, regulates intra-tumor immune cell infiltration, but the mechanics of their different roles in immunotherapy combinations require further investigation [12, 29, 30]. Here, KDR is linked to neoplasm.